New Drug Development for Medulloblastoma - Professor Louis Chester | Research into Brain Tumours

Medulloblastoma is the most common malignant brain tumour in children and causes 10% of cancer deaths. Large studies of tumour-tissue have identified four subgroups of medulloblastoma in patients, but only children with the two least aggressive subgroups have new treatment options. For those children with aggressive, “Group 3" tumours, survival is dismal and treatment is devastating.

For more information: https://www.thebraintumourchar....ity.org/quest-for-cu

• Kategorya